Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (MALS verified), Unconjugated

Catalog Number: ABS-SPD-M265-1MG
Article Name: Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (MALS verified), Unconjugated
Biozol Catalog Number: ABS-SPD-M265-1MG
Supplier Catalog Number: SPD-M265-1mg
Alternative Catalog Number: ABS-SPD-M265-1MG
Manufacturer: AcroBiosystems
Host: Human
Category: Antikörper
Species Reactivity: Human
Conjugation: Unconjugated
The antibody is isolated from the serum of COVID19 vaccine recipient and is recombinantly produced from human 293 cells (HEK293). This antibody can broadly neutralize SARSCoV2 Variants of Concerns (VOCs) including Alpha, Beta, Gamma, Delta and O
Tag: Human IgG1 | Human Kappa
Buffer: PBS, pH7.4
Source: The antibody is isolated from the serum of COVID-19 vaccine recipient and is recombinantly produced from human 293 cells (HEK293). This antibody can broadly neutralize SARS-CoV-2 Variants of Concerns (VOCs) including Alpha, Beta, Gamma, Delta and Omicron
Expression System: HEK293
Purity: 95%
Form: Powder
Target: Spike RBD
Antibody Type: Recombinant Antibody
SPD-M265-1mg